标题
Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis
作者
关键词
-
出版物
PHARMACOECONOMICS
Volume 38, Issue 2, Pages 233-242
出版商
Springer Science and Business Media LLC
发表日期
2019-12-03
DOI
10.1007/s40273-019-00864-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population
- (2018) Cameron Sikavi et al. HEPATOLOGY
- QALYs in 2018—Advantages and Concerns
- (2018) Peter J. Neumann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report [4]
- (2018) Patricia M. Danzon et al. VALUE IN HEALTH
- A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]
- (2018) Louis P. Garrison et al. VALUE IN HEALTH
- A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses
- (2018) Joseph Levy et al. VALUE IN HEALTH
- Engaging hepatitis C infected patients in cost-effectiveness analyses: A literature review
- (2017) T. Joseph Mattingly et al. HEPATOLOGY
- Methods and impact of engagement in research, from theory to practice and back again: early findings from the Patient-Centered Outcomes Research Institute
- (2017) Laura Forsythe et al. QUALITY OF LIFE RESEARCH
- Value to Whom? The Patient Voice in the Value Discussion
- (2017) Eleanor M. Perfetto et al. VALUE IN HEALTH
- The Probabilistic Efficiency Frontier: A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options
- (2017) Axel C. Mühlbacher et al. VALUE IN HEALTH
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
- (2016) Gillian D. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals
- (2016) Jagpreet Chhatwal et al. PHARMACOECONOMICS
- Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population
- (2016) Harinder S. Chahal et al. JAMA Internal Medicine
- Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US
- (2016) Sammy Saab et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus
- (2015) Mehdi Najafzadeh et al. ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
- (2015) Jagpreet Chhatwal et al. ANNALS OF INTERNAL MEDICINE
- Serum inorganic phosphorus levels predict 30-day mortality in patients with community acquired pneumonia
- (2015) Mohammad E. Naffaa et al. BMC INFECTIOUS DISEASES
- Patient-Focused Drug Development
- (2015) Eleanor M. Perfetto et al. MEDICAL CARE
- Patient-centric HTA: different strokes for different folks
- (2015) Axel C Mühlbacher Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection
- (2014) S. Saab et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in U.S. Incarcerated Populations
- (2014) Shan Liu et al. ANNALS OF INTERNAL MEDICINE
- Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
- (2014) Maxine M. Denniston et al. ANNALS OF INTERNAL MEDICINE
- New Protease Inhibitors for the Treatment of Chronic Hepatitis C
- (2013) Shan Liu et al. ANNALS OF INTERNAL MEDICINE
- The Burden of Untreated Hepatitis C Virus Infection: A US Patients’ Perspective
- (2012) Antoine C. El Khoury et al. DIGESTIVE DISEASES AND SCIENCES
- Continuous Patient Engagement in Comparative Effectiveness Research
- (2012) Abdulla M. Abdulhalim JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Distribution of hepatitis C virus genotypes in a diverse US integrated health care population
- (2012) M. Michele Manos et al. JOURNAL OF MEDICAL VIROLOGY
- Patient time costs and out-of-pocket costs in hepatitis C
- (2012) Carole A. Federico et al. LIVER INTERNATIONAL
- Model Transparency and Validation
- (2012) David M. Eddy et al. MEDICAL DECISION MAKING
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More
- (2011) B. L. Pearlman et al. CLINICAL INFECTIOUS DISEASES
- A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
- (2011) Jules L. Dienstag et al. HEPATOLOGY
- Trends in Organ Donation and Transplantation in the United States, 1999-2008
- (2010) R. A. Wolfe et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Defining Comparative Effectiveness Research
- (2010) Harold C. Sox MEDICAL CARE
- Legislating against Use of Cost-Effectiveness Information
- (2010) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Healthcare Rationing by Proxy
- (2010) John F.P. Bridges et al. PHARMACOECONOMICS
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started